An odd title; this patent was already struck down by the Supreme Court of the USA in 2013[0]. Now it&#x27;s no longer valid in Australia. The cost of tests for BRCA1&#x2F;2 mutations is dropping dramatically; were the medical apparatus of the USA not so drastically broken, the cost to consumers of this test would today cost the consumer around $50 US. This is thanks largely to the ACLU and some geneticists in NYC, including Harry Ostrer.<p>[0]: <a href="https:&#x2F;&#x2F;en.wikipedia.org&#x2F;wiki&#x2F;Myriad_Genetics#Association_for_Molecular_Pathology_v._Myriad_Genetics" rel="nofollow">https:&#x2F;&#x2F;en.wikipedia.org&#x2F;wiki&#x2F;Myriad_Genetics#Association_fo...</a>